Impact of Left Internal Mammary Artery–to–Left Anterior Descending Artery Anastomotic Location on Graft Patency: A Secondary Analysis of the PATENCY Trial Data Set
Journal of the American Heart Association · 2026
DOI: 10.1161/jaha.126.051333 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Chunyuan Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Unio…. Hauptthemen laut MEDLINE: Vascular Patency, Internal Mammary-Coronary Artery Anastomosis, Mammary Arteries, Coronary Vessels. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The impact of the left internal mammary artery (LIMA)–to–left anterior descending artery (LAD) anastomotic location on graft patency remains uncertain.
Methods
This study included 1597 patients with isolated proximal LAD lesions from the PATENCY (Graft Patency Between no‐touch Vein Harvesting Technique and Conventional Approach in Coronary Artery Bypass Graft Surgery) trial who underwent coronary artery bypass grafting. The relative anastomotic site (RAS) of the LIMA–LAD anastomosis was quantified using postoperative coronary computed tomography angiography and defined as the ratio of anastomotic height/heart height. The primary end point was LIMA occlusion at 3 years, and the secondary end point was major adverse cardiac events. Multivariable logistic regression was used to evaluate the association between RAS and 3‐year LIMA occlusion, and Cox proportional hazards regression was used to evaluate associations with time‐to‐event clinical outcomes.
Results
The exploratory RAS threshold was 46%. Distal anastomosis (RAS >46%) was associated with a significantly lower 3‐year LIMA occlusion rate compared with proximal anastomosis (RAS ≤46%) (2.3% versus 6.3%; adjusted odds ratio, 0.37 [95% CI, 0.20–0.68]; P =0.002). At 3 years, major adverse cardiac event rates were similar between groups (3.4% versus 4.4%; adjusted hazard ratio, 0.68 [95% CI, 0.40–1.15]; P =0.16).
Conclusions
In patients with isolated proximal LAD disease, a more distal LIMA–LAD anastomotic location may be associated with a lower risk of graft occlusion at 3 years. Further prospective validation is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
- Medical Research and Biometrics Center, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Be…
- Department of Radiology Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
ORCID-Profile: Chunyuan Wang, Yan Zhang, Zhan Hu
Zitieren
APA
Wang, C., Tian, M., Wang, Y., Hou, Z., Feng, W., Zhang, Y., & Hu, Z. (2026). Impact of Left Internal Mammary Artery–to–Left Anterior Descending Artery Anastomotic Location on Graft Patency: A Secondary Analysis of the PATENCY Trial Data Set. Journal of the American Heart Association. https://doi.org/10.1161/jaha.126.051333
Vancouver
Wang C, Tian M, Wang Y, Hou Z, Feng W, Zhang Y, et al. Impact of Left Internal Mammary Artery–to–Left Anterior Descending Artery Anastomotic Location on Graft Patency: A Secondary Analysis of the PATENCY Trial Data Set. Journal of the American Heart Association. 2026. doi:10.1161/jaha.126.051333
BibTeX
@article{Wang2026,
author = {Wang, Chunyuan and Tian, Meice and Wang, Yang and Hou, Zhihui and Feng, Wei and Zhang, Yan and Hu, Zhan},
title = {Impact of Left Internal Mammary Artery–to–Left Anterior Descending Artery Anastomotic Location on Graft Patency: A Secondary Analysis of the PATENCY Trial Data Set},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.126.051333}
}
EUVIMED